DKSH has signed an agreement to acquire Medipharm Sdn Bhd, a leading distributor of pharmaceutical and medical devices in Brunei, enhancing its market presence in the Asia-Pacific region.

Information on the Target

DKSH has signed an agreement to acquire Medipharm Sdn Bhd, a prominent distributor of pharmaceutical and medical devices in Brunei. This acquisition aligns with DKSH Healthcare's strategic initiative to expand its presence in the Asia-Pacific region.

Established in 1998, Medipharm has been a key player in the distribution of pharmaceutical products, medical devices, consumer health items, personal care, and nutritional products. The company generates annual net sales exceeding CHF 30 million and has built a solid reputation by serving well-known blue-chip clients, including hospitals, medical centers, clinics, opticians, and pharmacies.

Industry Overview in Brunei

The pharmaceutical and medical device industry in Brunei has seen steady growth, fueled by an increasing demand for healthcare services and an enhanced focus on improving public h

View Source

Similar Deals

Bambu Ventures Lemonaid Health

2026

Buyout Advanced Medical Equipment & Technology (NEC) United States of America
Medibank Better Medical

2026

Buyout Hospitals, Clinics & Primary Care Services Australia
OMERS Private Equity CBI Home Health

2026

Buyout Home Healthcare Services Canada
メディアスホールディングス 共栄医科器械

2026

Buyout Medical Equipment, Supplies & Distribution (NEC) Japan
XenoTherapeutics, Inc. Repare Therapeutics Inc.

2026

Buyout Bio Therapeutic Drugs Canada
ADR120S アスリートメッド

2026

Buyout Hospitals, Clinics & Primary Care Services Japan

DKSH

invested in

Medipharm Sdn Bhd

in 2024

in a Buyout deal

Disclosed details

Revenue: $20M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert